Angela Santoni Selected Research

CD226 antigen

1/2015	Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
10/2009	Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Santoni Research Topics

Disease

87	Neoplasms (Cancer) 04/2022 - 05/2001
25	Multiple Myeloma 01/2022 - 04/2009
12	Inflammation (Inflammations) 01/2021 - 11/2007
11	Glioma (Gliomas) 11/2021 - 07/2004
11	Infections 01/2020 - 10/2006
8	Virus Diseases (Viral Diseases) 10/2020 - 12/2004
6	Breast Neoplasms (Breast Cancer) 11/2012 - 05/2001
5	Pain (Aches) 04/2022 - 03/2017
5	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2019 - 07/2007
4	Cancer Pain 04/2022 - 07/2002
4	Hyperalgesia 04/2022 - 10/2019
4	Leukemia 01/2022 - 01/2015
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2004
4	Carcinoma (Carcinomatosis) 03/2014 - 03/2006
3	Melanoma (Melanoma, Malignant) 01/2019 - 11/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 04/2015 - 04/2002
2	Neuroinflammatory Diseases 04/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 11/2019 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2019 - 10/2018
2	Rheumatoid Arthritis 01/2019 - 03/2017
2	Lymphopenia (Lymphocytopenia) 10/2017 - 01/2016
2	Osteoarthritis 03/2017 - 01/2017
2	Necrosis 01/2017 - 02/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2015 - 07/2014
2	Lymphoma (Lymphomas) 03/2015 - 01/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 11/2007 - 02/2002
2	Carcinogenesis 03/2007 - 03/2006
1	Allergic Rhinitis 10/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Breakthrough Pain 01/2021
1	COVID-19 10/2020
1	Disease Progression 10/2020

Drug/Important Bio-Agent (IBA)

40	LigandsIBA 01/2022 - 03/2009
21	CytokinesIBA 01/2021 - 02/2002
15	ChemokinesIBA 01/2021 - 04/2002
13	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
12	micaIBA 01/2022 - 07/2007
8	Pharmaceutical PreparationsIBA 01/2020 - 04/2009
6	Monoclonal AntibodiesIBA 10/2021 - 05/2001
6	Antiviral Agents (Antivirals)IBA 10/2020 - 08/2006
5	Opioid Analgesics (Opioids)IBA 04/2022 - 07/2002
5	Biological ProductsIBA 10/2021 - 05/2001
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2005
5	Interleukin-15 (Interleukin 15)IBA 01/2021 - 05/2012
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2003
5	AntibodiesIBA 01/2019 - 05/2001
5	Peptides (Polypeptides)IBA 05/2016 - 05/2001
4	Immunomodulating AgentsIBA 01/2021 - 09/2015
4	NF-kappa B (NF-kB)IBA 02/2020 - 01/2005
4	AntigensIBA 01/2016 - 05/2004
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2019
3	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2016
3	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2019 - 01/2003
3	UbiquitinIBA 01/2019 - 01/2003
3	EpitopesIBA 01/2019 - 03/2008
3	Messenger RNA (mRNA)IBA 07/2016 - 07/2010
3	Chemokine ReceptorsIBA 11/2015 - 08/2004
3	Protein Isoforms (Isoforms)IBA 11/2015 - 03/2007
3	Epidermal Growth Factor (EGF)IBA 12/2010 - 03/2006
3	Indicators and Reagents (Reagents)IBA 12/2010 - 05/2001
2	Histone Deacetylases (Histone Deacetylase)IBA 11/2021 - 01/2015
2	TubulinIBA 11/2021 - 08/2015
2	InterleukinsIBA 01/2021 - 10/2006
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2016
2	Liver X ReceptorsIBA 01/2020 - 01/2019
2	CholesterolIBA 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 09/2019 - 12/2004
2	Interleukin-12 (IL 12)IBA 09/2019 - 10/2006
2	Small Interfering RNA (siRNA)IBA 06/2019 - 07/2010
2	Immunoglobulin G (IgG)IBA 01/2019 - 05/2004
2	Rituximab (Mabthera)FDA Link 10/2017 - 03/2015
2	Axitinib (AG 013736)IBA 01/2017 - 11/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 11/2015
2	Docosahexaenoic AcidsIBA 01/2017 - 02/2016
2	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 01/2016
2	CationsIBA 12/2016 - 07/2016
2	Interferon-gamma (Interferon, gamma)IBA 12/2016 - 02/2002
2	Granzymes (Granzyme)IBA 02/2016 - 09/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 01/2015
2	CD226 antigenIBA 01/2015 - 10/2009
2	poliovirus receptorIBA 01/2015 - 06/2013
2	VaccinesIBA 03/2014 - 04/2010
2	Poly I-CIBA 12/2013 - 12/2004
2	ErbB Receptors (EGF Receptor)IBA 12/2010 - 05/2001
2	Chemokine CX3CL1IBA 07/2010 - 04/2010
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2007 - 02/2002
1	Morphine (MS Contin)FDA LinkGeneric 04/2022
1	Opioid Receptors (Opioid Receptor)IBA 04/2022
1	Signaling Lymphocytic Activation Molecule Family Member 1IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	PCI 34051IBA 11/2021
1	EnzymesIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 10/2020

Therapy/Procedure

27	Therapeutics 01/2021 - 04/2002
7	Drug Therapy (Chemotherapy) 01/2020 - 07/2004
7	Immunotherapy 01/2020 - 04/2002
2	Ligation 04/2020 - 01/2018
2	Stem Cell Transplantation 01/2017 - 01/2015
1	Analgesia 10/2020